stephen silberstein, md, director, jefferson university headache center..
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
.andrew kaye, head of policy at macmillan cancer support said it was �shocking� that a cancer patient had to wait 541 days for treatment..
.
.